Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-02-25 @ 4:56 PM
Study NCT ID:
NCT05945732
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2023-07-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DESTINY Breast Respond HER2-low Europe
Sponsor:
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DS8201-0005-NIS-MA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None